Expanding the Plant-Based Food Portfolio and North American and Overseas Operations through the Acquisition of Daiya Foods
First written in FY2017-Q2. 7 of 21 entries say "Restated". Latest entry: FY2025.
Otsuka Holdings moved to the "Worse" side of this theme in 2023.
The whole theme swung hardest in 2026: 1 of 9 companies on the "Worse" side.
0 other companies' latest entry also says "Worsened".
- FY2025WorsenedAnnual report
「As profitability is expected to decline due to weakness in the North American plant-based food market, the carrying amount of assets related to Daiya Foods was reduced to their recoverable amount, and an impairment loss of ¥11,349 million was recognized.」
For Daiya Foods, the decline in profitability resulting from weakness in the North American plant-based food market materialized as an impairment loss. - FY2024RestatedAnnual report
「Revenue in the nutraceuticals-related business increased, as all categories grew, led by Pocari Sweat and Nature Made, across the three new categories organized by social issue and designated as growth drivers.」
The product portfolio of the nutraceuticals-related business, including Daiya Foods, continues to be managed across categories organized by social issue and new geographic expansions. - FY2024-Q1RestatedAnnual report
「The Daiya Foods brand of plant-based foods continues to expand its product lineup and distribution by leveraging its proprietary technologies. Despite intensified competition and other factors in North America's dairy-alternative cheese market, revenue increased due to foreign-exchange effects.」
While competition in North America's dairy-alternative cheese market continues to intensify, the company continues to expand its product lineup and distribution by leveraging its proprietary technologies. - FY2023WorsenedAnnual report
「The Daiya Foods brand of plant-based foods posted lower revenue due to intensified competition and other factors in North America's dairy-alternative cheese market.」
Revenue continued to decline due to intensified competition, and an impairment loss of ¥24,828 million was also recognized for Daiya Foods. - FY2023-Q3WorsenedAnnual report
「The Daiya Foods brand of plant-based foods posted lower revenue due to intensified competition and other factors in North America's dairy-alternative cheese market, but the company continues to expand its product lineup and distribution by leveraging its proprietary technologies.」
Revenue from the Daiya Foods brand declined due to intensified competition and other factors, and an impairment loss of ¥22,229 million was also recognized for the nine-month period ended the third quarter. Meanwhile, expansion of the product lineup and distribution is continuing. - FY2023-Q2WorsenedAnnual report
「The Daiya Foods brand of plant-based foods posted lower revenue due to intensified competition and other factors in North America's dairy-alternative cheese market, but the company continues to expand its product lineup and distribution by leveraging its proprietary technologies.」
Revenue from the Daiya Foods brand declined due to intensified competition and other factors, and an impairment loss of ¥21,706 million was recognized. Meanwhile, expansion of the product lineup and distribution is continuing. - FY2022-Q1AdvancedAnnual report
「The Daiya Foods brand of plant-based foods has maintained the leading share of North America's dairy-alternative cheese market, supported by proactive initiatives including new product launches and expansion of production facilities.」
The Daiya Foods brand has maintained the leading share of North America's dairy-alternative cheese market and is pursuing new product launches and production-facility expansion. Revenue declined slightly due to transportation disruptions and other factors, but expansion of the product lineup and distribution is continuing. - FY2021Revenue decline continuesAnnual report
「Despite a decline in revenue during the consolidated fiscal year, partly due to the lapping of the sharp increase in at-home demand accompanying the COVID-19 pandemic in the previous year, the company continues to expand its product lineup and distribution by leveraging its proprietary technologies.」
The Daiya Foods brand maintained a high market share, but revenue declined due to the lapping of the increase in at-home demand in the previous year. Expansion of the product lineup and distribution is continuing. - FY2021-Q3RestatedAnnual report
「The Daiya Foods brand of plant-based foods has maintained a high market share in North America's dairy-alternatives market. Meanwhile, the number of new market entrants is increasing as the market expands rapidly. Despite a decline in revenue during the nine-month period ended the third quarter, partly due to the lapping of the sharp increase in at-home demand accompanying the COVID-19 pandemic in the same quarter of the previous year, the company continues to expand its product lineup and distribution by leveraging its proprietary technologies.」
The Daiya Foods brand maintained a high market share, but revenue declined due to an increase in new market entrants and the lapping of the increase in at-home demand in the previous year. Expansion of the product lineup and distribution through proprietary technologies is continuing. - FY2021-Q2Revenue Decline Due to Intensifying Competition and Lapping EffectsAnnual report
「The Daiya Foods brand of plant-based foods has maintained a high market share in North America's dairy-alternatives market. Meanwhile, the number of new market entrants is increasing as the market expands rapidly. Despite a decline in revenue during the six-month period ended the second quarter, partly due to the lapping of the sharp increase in at-home demand accompanying the COVID-19 pandemic in the same quarter of the previous year, the company continues to expand its product lineup and distribution by leveraging its proprietary technologies.」
The Daiya Foods brand maintained a high market share, but revenue declined in the six months ended the second quarter due to an increase in new market entrants and the lapping of the sharp increase in at-home demand in the previous year. Expansion of the product lineup and distribution is continuing. - FY2020AdvancedAnnual report
「The Daiya Foods brand of plant-based foods posted substantial revenue growth in North America, due to growth in the dairy-alternatives market and increased at-home demand.」
Revenue from the three development brands, including the Daiya Foods brand, increased 28.0% year on year to ¥27,162 million, demonstrating growth in the North American plant-based food business. - FY2020-Q3AdvancedAnnual report
「Combined revenue from the Daiya Foods brand, Equelle and Body Maintenance, designated as the three development brands, increased 27.7% year on year to ¥20,189 million.」
Revenue from the three development brands, including the Daiya Foods brand, increased 27.7% year on year. The Daiya Foods brand posted substantial revenue growth due to growth in the cheese-alternatives market and increased at-home demand. - FY2020-Q2AdvancedAnnual report
「Combined revenue from the Daiya Foods brand, Equelle and Body Maintenance, designated as the three development brands, increased 32.1% year on year to ¥13,183 million.」
Revenue from the three development brands, including the Daiya Foods brand, increased 32.1% year on year, demonstrating the growth of the plant-based food portfolio since the acquisition. - FY2019RestatedAnnual report
「The Daiya Foods brand of plant-based foods generated higher revenue in North America, driven by growth in cheese alternatives and new products compared with the previous fiscal year.」
The disclosure continues to describe growth in Daiya Foods' North American plant-based food business since the acquisition. Combined revenue from the three development brands increased 18.0% year on year. - FY2019-Q3AdvancedAnnual report
「Combined revenue from the Daiya Foods brand, Equelle and Body Maintenance, designated as the three development brands, increased 28.5% year on year to ¥15,806 million.」
Revenue from the three development brands, including the Daiya Foods brand, increased 28.5% year on year. The disclosure describes growth in cheese alternatives and new products under the Daiya Foods brand. - FY2019-Q1RestatedAnnual report
「Growth in overseas sales volumes of Pocari Sweat, a hydration and electrolyte beverage, substantial revenue growth accompanying the expansion of new customers for Equelle, a food containing equol, and higher revenue at Daiya Foods, which develops, manufactures and sells plant-based foods in North America, contributed to the increase.」
Higher revenue at Daiya Foods contributed to sales in the nutraceuticals-related business, and the disclosure continues to describe growth in the North American plant-based food business since the acquisition. - FY2018-Q3RestatedAnnual report
「Daiya Foods, which develops, manufactures and sells plant-based foods in North America, continues to report higher revenue.」
The disclosure continues to report revenue growth in Daiya Foods' North American plant-based food business since the acquisition. - FY2018-Q2RestatedAnnual report
「Daiya Foods, which became a consolidated subsidiary in September 2017, develops, manufactures and sells plant-based foods in North America and continues to grow.」
The disclosure states that Daiya Foods' North American plant-based food business has continued to grow since the acquisition. - FY2017Cited as achievedAnnual report
「The acquisition was completed on 31 August 2017.」
The completion of the acquisition of all shares of Daiya Foods is reiterated as an achievement in business combination and product-portfolio expansion. - FY2017-Q3AchievedAnnual report
「Otsuka Pharmaceutical Co., Ltd., a consolidated subsidiary of the company, entered into an agreement dated 26 July 2017 (local time) to acquire all shares of Daiya Foods Inc., which develops, manufactures and sells plant-based foods in North America, through a Canadian acquisition vehicle established by Otsuka Pharmaceutical Co., Ltd. The acquisition was completed on 31 August 2017.」
The acquisition of all shares of Daiya Foods, for which the agreement was disclosed in the second quarter, was completed on 31 August 2017. The plan to incorporate North America's plant-based food category into the NC-related business advanced to the acquisition-completion stage. - FY2017-Q2First statedAnnual report
「Through this acquisition, the company aims to strengthen its product portfolio in the NC-related business by adding a new product category, expand the business in North America, and achieve further growth for both companies through the sharing of research and development, manufacturing technologies and expertise. Daiya also plans to expand its distribution channels in Europe and Asia, and Otsuka Pharmaceutical Co., Ltd. intends to promote the global expansion of the NC-related business together with Daiya through innovative products, thereby contributing to the health of people worldwide.」
On 26 July 2017, the company entered into an agreement to acquire all shares of Daiya Foods Inc., which develops plant-based and dairy-free foods, for C$405 million. The target company's sales approximately tripled from 2013 to 2016, and its net sales for the latest 12 months were approximately C$90 million. The acquisition was expected to close following approval by shareholders, the court and other parties, and was disclosed as a significant acquisition plan after the end of the quarter.